跳至主要内容
临床试验/CTRI/2019/05/019345
CTRI/2019/05/019345尚未招募4 期

To compare the Safety and Efficacy of Teneligliptin with Vildagliptin add-on, in patients of uncontrolled Type 2 diabetes mellitus (T2DM), on Metformin monotherapy.

Dr Arun Kumar Negi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. All willing patients of either sex.
  • 2. Patients with type 2 diabetes mellitus (T2DM).
  • 3. Patients with uncontrolled T2DM on 2 gram metformin dose.
  • 4. Patients having HbA1c level >=7 %.
  • 5. Patients fasting plasma glucose (FPG) levels >= 126 mg/dL or post prandial glucose (PPG) >= 200 mg/dL.

排除标准

  • 1. All unwilling patients.
  • 2. Acute complications of diabetes
  • i. Hyperglycemic hyperosmolar state
  • ii. Diabetic ketoacidosis
  • 3. Liver Disease
  • 4. Congestive heart failure
  • 5. Acute coronary syndrome
  • 6. Pregnancy and lactating mothers
  • 7. Known hypersensitivity to study drugs
  • 8. Patients already on study drugs

研究者

发起方
Dr Arun Kumar Negi

相似试验